TaiwanJ Pharmaceuticals Co (ROCO:6549) Research & Development: NT$9.68 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6549 TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
21 GF Score
Price NT$6.88
! 2 Warning Signs
View Full Analysis

What is TaiwanJ Pharmaceuticals Co Research & Development?

TaiwanJ Pharmaceuticals Co ROCO:6549 -1.57% 21 Research & Development is NT$9.68 Mil as of Jun. 2026. GuruFocus rates ROCO:6549 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. TaiwanJ Pharmaceuticals Co's Research & Development for the six months ended in Jun. 2026 was NT$4.05 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was NT$9.68 Mil.

TaiwanJ Pharmaceuticals Co  (ROCO:6549) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TaiwanJ Pharmaceuticals Co Research & Development Related Terms

TaiwanJ Pharmaceuticals Co Research & Development Historical Data

* Premium members only.

The historical data trend for TaiwanJ Pharmaceuticals Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TaiwanJ Pharmaceuticals Co Research & Development Chart

TaiwanJ Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.73 12.74 13.97 11.31 10.70

TaiwanJ Pharmaceuticals Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.76 5.55 5.06 5.64 4.05
ROCO:6549
21GF Score
TaiwanJ Pharmaceuticals Co Ltd ROCO:6549
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TaiwanJ Pharmaceuticals Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$9.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$9.68 Mil mean?
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a Research & Development of NT$9.68 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on TaiwanJ Pharmaceuticals Co and its competitors.
Is TaiwanJ Pharmaceuticals Co's Research & Development too high?
TaiwanJ Pharmaceuticals Co's current Research & Development is NT$9.68 Mil. Overall, TaiwanJ Pharmaceuticals Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does TaiwanJ Pharmaceuticals Co's Research & Development compare to VRTX and REGN?
TaiwanJ Pharmaceuticals Co's Research & Development of NT$9.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. TaiwanJ Pharmaceuticals Co's current Research & Development is NT$9.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiwanJ Pharmaceuticals Co stock overvalued right now?
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a current Research & Development of NT$9.68 Mil. The current Research & Development is NT$9.68 Mil. TaiwanJ Pharmaceuticals Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For TaiwanJ Pharmaceuticals Co (ROCO:6549), the current Research & Development is NT$9.68 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TaiwanJ Pharmaceuticals Co Business Description

Address No. 6-1, Shengyi Road, 3F-4, Section 2, Hsinchu County, Zhubei, TWN, 30261
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
21GF Score

Get the complete analysis for ROCO:6549

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.88
Price